Adrian Mark Freeman
0009-0007-0413-5657
AstraZeneca (United Kingdom)
4 papers found
Refreshing results…
Unlocking collaborations
11β-HSD1 inhibitor efficacy in type 2 diabetes is cortisol-dependent
Inhibition of the glucocorticoid‐activating enzyme 11β‐hydroxysteroid dehydrogenase type 1 drives concurrent 11‐oxygenated androgen excess
Machine Learning and Artificial Intelligence in drug repurposing – challenges and perspectives
Missing publications? Search for publications with a matching author name.